English
Korean
GBIOLOGICS

Biotechnology company

GBIOLOGICS
홈으로
GBIOLOGICS
History
History
2019

GB910 co-development MOA with a pharma company

GB500 MTA with an IVD company

Series A fund-raising ($2M)

R&D Center opened

sGal-9 selected as IP-R&D Project

sGal-9 production process optimization

sGal-9 awarded a TIPS(Tech Incubator Program for Startup Korea) investment from Chungbuk Center for Creative Economy and Innovation(CCEI)

Lucentis biosimilar phase I/II clinical trials completed (24 patients at Yonsei Severance Hospital, Korea)

2018

sGal-9 new material patent (USA/Japan) ownership acquired

Incorporation of GBIO